90 filings
Page 2 of 5
8-K
a8npf
10 Aug 23
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
8:12am
8-K
qs7gk8zak54p
26 Jul 23
Departure of Directors or Certain Officers
4:06pm
8-K
d2nqjnbd0igkyb5wm11a
21 Jun 23
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
4:05pm
8-K
n1aa9 icpylvpa
12 May 23
Vaccitech Reports First Quarter 2023 Financial Results and Recent Corporate Developments
8:16am
8-K
osp7g385
11 May 23
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
j9wlpcs5v8prmbq6ef0
28 Apr 23
Departure of Directors or Certain Officers
12:00am
ARS
os96l u5nxgrz
19 Apr 23
Annual report to shareholders
5:04pm
S-8
nppp38cr vl
24 Mar 23
Registration of securities for employees
8:38am
8-K
eahw4o
24 Mar 23
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
8:16am
8-K
137otcbna
10 Nov 22
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
4:50pm
8-K/A
agppcgbqc5ea5m
30 Sep 22
Departure of Directors or Certain Officers
4:05pm
8-K
uecryk4z8pmkuh
20 Sep 22
Departure of Directors or Certain Officers
4:34pm
EFFECT
28i2c6uiymyg
18 Aug 22
Notice of effectiveness
12:15am
CORRESP
0xxjnbxx5p 6u3
15 Aug 22
Correspondence with SEC
12:00am
UPLOAD
2lui60yc2
12 Aug 22
Letter from SEC
12:00am
S-3/A
m8zd1y2w8 txcdrzb
10 Aug 22
Shelf registration (amended)
4:17pm